GNH USA

Europe — EMA

Lamivudine Arrow

GNH USA supplies Lamivudine Arrow (Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV infection and chronic hepatitis B.

Lamivudine

Request sourcing

1
Pack/s

What is Lamivudine?

Lamivudine, the active ingredient in Lamivudine Arrow, is a nucleoside reverse transcriptase inhibitor presented as an oral dosage form for oral use. It is prescribed to treat human immunodeficiency virus (HIV) infection and chronic hepatitis B infection in adult patients, and is administered under medical supervision.

GNH USA supplies Lamivudine Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The company adheres to EU quality standards and offers comprehensive logistics support.

What is Lamivudine used for?

Lamivudine is used in antiretroviral therapy and antiviral treatment of hepatitis B.

- HIV infection: reduces plasma HIV‑1 RNA levels, increases CD4+ T‑cell counts, and delays disease progression in adults. - Chronic hepatitis B infection: suppresses HBV DNA replication, improves liver enzyme profiles, and reduces risk of cirrhosis and hepatocellular carcinoma. - Prevention of mother‑to‑child transmission of HIV: administered during pregnancy and delivery to lower the chance of neonatal infection.

What are the side effects of Lamivudine?

Lamivudine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Fatigue

Serious or Rare Side Effects: - Lactic acidosis - Severe hepatotoxicity - Pancreatitis

What precautions apply to Lamivudine?

When prescribing Lamivudine Arrow, consider the following precautions: - Renal function: assess baseline renal function and adjust dose in patients with impairment. - Hepatic disease: monitor liver enzymes regularly in patients with pre‑existing liver disease. - Pregnancy: weigh potential benefits against risks; use only if clearly needed. - Concomitant antiretrovirals: avoid overlapping toxicities and review drug regimen. - Adherence: encourage strict adherence to maintain viral suppression. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

What does Lamivudine interact with?

Lamivudine Arrow can interact with other medicines; review the following:

Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis; avoid co‑administration. - Stavudine: additive mitochondrial toxicity; avoid combined use. - Ribavirin: may enhance hematologic toxicity; avoid.

Moderate Interactions (Monitor Closely): - Tenofovir: monitor renal function due to combined nephrotoxic potential. - Efavirenz: may affect lamivudine plasma levels; adjust monitoring.

Frequently asked questions

What is Lamivudine Arrow used for?+
Lamivudine Arrow is prescribed for the treatment of human immunodeficiency virus (HIV) infection and chronic hepatitis B infection. It helps lower viral load, improve immune function in HIV‑positive patients, and suppresses hepatitis B virus replication to reduce liver disease progression.
How does lamivudine work?+
Lamivudine is a nucleoside analogue that is converted inside cells to its active triphosphate form. This active metabolite competes with natural nucleotides for incorporation by HIV reverse transcriptase and hepatitis B virus DNA polymerase, causing premature termination of viral DNA synthesis and thereby inhibiting viral replication.
What is the usual dose of Lamivudine Arrow?+
The appropriate dose of Lamivudine Arrow is determined by the prescribing healthcare professional based on the individual’s clinical condition, weight, renal function and treatment regimen. Patients should follow the exact dosing instructions provided by their prescriber and not adjust the dose on their own.
Is Lamivudine Arrow safe during pregnancy or breastfeeding?+
Safety of Lamivudine Arrow in pregnancy or lactation should be evaluated by a qualified clinician. The potential benefits to the mother must be weighed against any possible risks to the fetus or infant. Use is generally considered only when clearly needed, and breastfeeding decisions should follow local guidelines.
How do I order Lamivudine Arrow from GNH USA?+
To order Lamivudine Arrow, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Lamivudine compare with other antiretroviral agents?+
Lamivudine belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class and is often combined with other antiretrovirals for synergistic effect. Compared with some older NRTIs, lamivudine has a favorable safety profile, lower mitochondrial toxicity, and is effective against both HIV and hepatitis B, making it a versatile component of combination regimens.
What are the recommended storage conditions for Lamivudine Arrow?+
Lamivudine Arrow should be stored at temperatures below 25 °C in its original packaging. Protect the product from moisture, direct sunlight and excessive heat. Keep the container tightly closed and out of reach of children to maintain potency throughout its shelf life.
How is Lamivudine Arrow administered?+
Lamivudine Arrow is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets (or other oral dosage form) should be swallowed whole with a glass of water. Patients should not crush, chew, or split the tablets unless specifically instructed.
What are the most serious risks associated with Lamivudine Arrow?+
Serious adverse events, although rare, include lactic acidosis, severe hepatotoxicity and pancreatitis. These conditions can be life‑threatening and require immediate medical attention. Patients should be monitored for signs such as unexplained fatigue, abdominal pain, jaundice or rapid breathing, and report any concerning symptoms promptly.
Who should not use Lamivudine Arrow?+
Lamivudine Arrow should be avoided in individuals with known hypersensitivity to lamivudine or any of its excipients. Caution is also advised for patients with severe renal or hepatic impairment, and those taking contraindicated medications such as didanosine, stavudine or ribavirin without proper medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lamivudine
Route
Oral Use
Manufacturer
Arrow Generiques
Origin
EU

Related products